SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001420720-22-000024
Filing Date
2022-05-12
Accepted
2022-05-12 16:17:53
Documents
106
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20220331x10q.htm   iXBRL 10-Q 2748274
2 EX-10.1 ibio-20220331xex10d1.htm EX-10.1 51923
3 EX-31.1 ibio-20220331xex31d1.htm EX-31.1 18160
4 EX-31.2 ibio-20220331xex31d2.htm EX-31.2 17847
5 EX-32.1 ibio-20220331xex32d1.htm EX-32.1 7608
6 EX-32.2 ibio-20220331xex32d2.htm EX-32.2 6768
7 GRAPHIC ibio-20220331x10q001.jpg GRAPHIC 99076
8 GRAPHIC ibio-20220331xex10d1003.jpg GRAPHIC 899
  Complete submission text file 0001420720-22-000024.txt   11744490

Data Files

Seq Description Document Type Size
9 EX-101.SCH ibio-20220331.xsd EX-101.SCH 93807
10 EX-101.CAL ibio-20220331_cal.xml EX-101.CAL 99914
11 EX-101.DEF ibio-20220331_def.xml EX-101.DEF 235910
12 EX-101.LAB ibio-20220331_lab.xml EX-101.LAB 596205
13 EX-101.PRE ibio-20220331_pre.xml EX-101.PRE 506894
100 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20220331x10q_htm.xml XML 2324013
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 22918056
SIC: 2834 Pharmaceutical Preparations